Edition:
United States

Agilent Technologies Inc (A)

A on New York Consolidated

53.08USD
24 Mar 2017
Change (% chg)

$-0.10 (-0.19%)
Prev Close
$53.18
Open
$54.05
Day's High
$54.05
Day's Low
$52.84
Volume
2,015,289
Avg. Vol
2,043,255
52-wk High
$54.82
52-wk Low
$38.89

Latest Key Developments (Source: Significant Developments)

Agilent Technologies Inc announces cash dividend
Thursday, 19 Nov 2015 04:05pm EST 

Agilent Technologies Inc:Says increased the company's quarterly dividend to 11.5 cents per share of common stock.Paid on Jan. 27, 2016, to all shareholders of record as of the close of business on Jan. 5, 2016.  Full Article

Agilent Technologies Inc gives Q1, FY 2016 guidance below analysts' estimates
Monday, 16 Nov 2015 04:05pm EST 

Agilent Technologies Inc:Sees Q1 2016 revenue guidance of $1.0 billion to $1.02 billion, and non-GAAP earnings guidance of $0.42 to $0.44 per share.Sees FY 2016 revenue guidance of $4.15 billion to $4.17 billion, and non-GAAP earnings guidance of $1.85 to $1.91 per share.Q1 2016 revenue of $1.05 billion and EPS of $0.46 - Thomson Reuters I/B/E/S.FY 2016 revenue of $4.20 billion and EPS of $1.97 - Thomson Reuters I/B/E/S.  Full Article

Dako, an Agilent Technologies Inc Company, Announces FDA Approval of New Test for Lung Cancer Patients
Monday, 12 Oct 2015 02:06am EDT 

Agilent Technologies Inc:Dako, says that the U.S. Food and Drug Administration has approved a new test that can identify PD-L1 expression levels on the surface of non-small cell lung cancer tumor cells and provide information on the survival benefit with OPDIVO (nivolumab) for patients with non-squamous NSCLC.  Full Article

Agilent Technologies Inc announces cash dividend of 10 cents per share
Wednesday, 16 Sep 2015 04:05pm EDT 

Agilent Technologies Inc:Says quarterly dividend of 10 cents per share of common stock will be paid on Oct. 21, to all shareholders of record as of close of business on Sept. 29.  Full Article

Agilent Technologies, Inc acquire Seahorse Bioscience
Wednesday, 9 Sep 2015 04:05pm EDT 

Agilent Technologies, Inc:To acquire seahorse bioscience, industry leader in tools for measuring cell metabolism.Deal for $235 million.Says transaction is expected to be accretive in FY 2016 to Agilent and will be debt financed.  Full Article

Agilent Technologies Inc collaborating with Weill Cornell Medical College to Advance Research in ALS
Wednesday, 26 Aug 2015 11:00am EDT 

Agilent Technologies Inc:Says is collaborating with Steven Gross, a faculty member in the Department of Pharmacology at Weill Cornell Medical College, in New York, N.Y., to advance research in amyotrophic lateral sclerosis, also known as Lou Gehrig's disease.Agilent will provide the latest mass spectrometry technology to support his research.  Full Article

Agilent Technologies Inc lowers FY 2015 revenue guidance; narrows FY 2015 EPS guidance; gives Q4 2015 guidance; revenue guidance below analysts' estimates
Monday, 17 Aug 2015 04:05pm EDT 

Agilent Technologies Inc:Expects Q4 2015 revenue in the range of $1.03 billion to $1.05 billion.Expects Q4 2015 non-GAAP earnings to be in the range of $0.45 to $0.49 per share.Expects FY 2015 revenue of $4.03 billion to $4.05 billion.Expects FY 2015 non-GAAP earnings of $1.68 to $1.72 per share.Q4 2015 revenue of $1.06 billion and EPS of $0.49 - Thomson Reuters I/B/E/S.FY 2015 revenue of $4.06 billion and EPS of $1.70 - Thomson Reuters I/B/E/S.  Full Article

Agilent Technologies Inc authorizes new share repurchase program
Thursday, 28 May 2015 08:30am EDT 

Agilent Technologies Inc:Approves a new share repurchase program.Says 2015 Stock Repurchase Program authorizes the purchase of up to $1.14 bln of the company's common stock through and including Nov. 1, 2018.New program will commence, at the option of the company, on either Nov. 1 or the date on which the company completes the purchase of $365 mln of common stock under the existing stock repurchase program in fiscal 2015.Upon commencement, the new repurchase program replaces Agilent's existing stock repurchase program, which authorized the repurchase of shares to reduce or eliminate share dilution from equity programs.Number of shares to be repurchased and the timing of any repurchases will depend on factors such as the stock price, economic and market conditions, and corporate and regulatory requirements.Says stock repurchase program may be suspended or discontinued at any time.  Full Article

Agilent Technologies Inc announces cash dividend of 10 cents per share
Wednesday, 20 May 2015 04:05pm EDT 

Agilent Technologies Inc:Says quarterly dividend of 10 cents per share of common stock.Payable on July 22 to all shareholders of record date as on June 30.  Full Article

Agilent Technologies Inc gives Q3 2015 guidance in line with analysts' estimates; lowers FY 2015 revenue guidance; reaffirms FY 2015 EPS guidance
Monday, 18 May 2015 04:03pm EDT 

Agilent Technologies Inc:Expects Q3 2015 revenues to be in the range of $995 million to $1.015 billion.Expects Q3 2015 non-GAAP earnings to be in the range of $0.38 to $0.42 per share.Expects FY 2015 revenues of $4.05 billion to $4.11 billion.Expects FY 2015 non-GAAP earnings of $1.67 to $1.73 per share.Q3 2015 revenue of $1.000 billion and EPS of $0.42 - Thomson Reuters I/B/E/S.FY 2015 revenue of $4.069 billion and EPS of $1.69 - Thomson Reuters I/B/E/S.  Full Article

More From Around the Web

BRIEF-Agilent Technologies introduces a new target enrichment solution for next-generation DNA sequencing

* Introduced a new target enrichment solution for next-generation DNA sequencing Source text for Eikon: Further company coverage: